Day One Biopharmaceuticals, Inc.

Nasdaq:DAWN

Pharmaceutical Preparations·BRISBANE, CA

A day is the time period of a full rotation of the Earth with respect to the Sun. On average, this is 24 hours.

Financials

20 shown

Type	Period	Ended	Filed
10-K	FY 2025	12/31/25	2/24/26	→
10-Q	Q3 2025	9/30/25	11/4/25	→
10-Q	Q2 2025	6/30/25	8/5/25	→
10-Q	Q1 2025	3/31/25	5/6/25	→
10-K/A	FY 2024	12/31/24	3/6/25	→
10-K	FY 2024	12/31/24	2/25/25	→
↓

Earnings Releases (8-K)

21 shown

Filed	Period
2/24/26	Q1 FY2026	→
1/12/26	Q4 FY2026	→
11/4/25	Q4 FY2025	→
8/5/25	Q3 FY2025	→
5/6/25	Q2 FY2025	→
2/25/25	Q1 FY2025	→
↓

News (8-K)

41 shown

Filed	Type	Description
3/6/26	Agreement	Entry into a Material Definitive Agreement	→
3/2/26	Reg FD	Regulation FD Disclosure	→
1/6/26	Acquisition	Entry into a Material Definitive Agreement	→
11/24/25	Reg FD	Regulation FD Disclosure	→
11/13/25	Agreement	Entry into a Material Definitive Agreement	→
10/10/25	Exec Change	Departure or Appointment of Directors or Certain Officers	→
↓

Prospectuses & Registrations

20 shown

Filed	Form	Description
4/11/25	ARS	ARS	→
1/10/25	S-8	S-8	→
8/28/24	S-3ASR	S-3ASR	→
4/5/24	ARS	ARS	→
1/4/24	S-8	S-8	→
9/14/23	S-3ASR	S-3ASR	→
↓

Filing History(449 filings)

TypeDateAccessionPeriodSize

SC TO-C

Mar 6, 2026

0001193125-26-095178SC TO-C

—

60.2 KB

SC14D9C

Mar 6, 2026

0001193125-26-095176SC14D9C

—

121.9 KB

8-K

Mar 6, 2026

0001193125-26-0951748-K

Mar 6, 2026

814.9 KB

8-K

Mar 2, 2026

0001193125-26-0842678-K

Mar 2, 2026

17.7 MB

10-K

Feb 24, 2026

0001193125-26-06695610-K

Dec 31, 2025

19.2 MB

8-K

Feb 24, 2026

0001193125-26-0669268-K

Feb 24, 2026

28.0 MB

Feb 18, 2026

0001855298-26-000004

Feb 15, 2026

20.3 KB

Feb 18, 2026

0001744507-26-000004

Feb 15, 2026

23.8 KB

Feb 18, 2026

0001655962-26-000004

Feb 15, 2026

20.0 KB

Feb 18, 2026

0001863107-26-000004

Feb 15, 2026

25.2 KB

Feb 18, 2026

0001734755-26-000004

Feb 15, 2026

9.5 KB

144

Feb 17, 2026

0001950047-26-001417

—

4.8 KB

144

Feb 17, 2026

0001950047-26-001416

—

4.8 KB

144

Feb 17, 2026

0001950047-26-001414

—

4.8 KB

144

Feb 17, 2026

0001950047-26-001412

—

4.8 KB

SCHEDULE 13G

Feb 17, 2026

0000902664-26-001078

—

14.8 KB

SCHEDULE 13G/A

Feb 5, 2026

0000315066-26-000409

—

11.4 KB

Jan 30, 2026

0001655962-26-000002

Jan 30, 2026

8.1 KB

Jan 30, 2026

0001734755-26-000002

Jan 30, 2026

8.1 KB

Jan 30, 2026

0001863107-26-000002

Jan 30, 2026

8.1 KB

Jan 30, 2026

0001855298-26-000002

Jan 30, 2026

8.1 KB

Jan 30, 2026

0001744507-26-000002

Jan 30, 2026

8.1 KB

8-K

Jan 12, 2026

0001193125-26-0098348-K

Jan 11, 2026

8.2 MB

8-K

Jan 6, 2026

0001104659-26-001127FORM 8-K

Jan 6, 2026

8.5 MB

SC TO-T/A

Jan 6, 2026

0001104659-26-001116SC TO-T/A

—

53.6 KB

25 filings shown

Day One Biopharmaceuticals, Inc.

Financials

Earnings Releases (8-K)

News (8-K)

Prospectuses & Registrations

Filing History(449 filings)

Proxies

Ownership

Other Filings

Filed	Form	Description
4/11/25	DEFA14A	DEFA14A	→
4/11/25	DEF 14A	DEF 14A	→
4/5/24	DEFA14A	DEFA14A	→
4/5/24	DEF 14A	DEF 14A	→
4/28/23	DEFA14A	DEFA14A	→
4/28/23	DEF 14A	DEF 14A	→
↓

Filed	Form	Description
2/18/26	4	4	→
2/18/26	4	4	→
2/18/26	4	4	→
2/18/26	4	4	→
2/18/26	4	4	→
1/30/26	4	4	→
↓